Product Program year 2020 Source: CMS Open Payments

Eluvia

Device Stents

Open in the dashboard

General payments

$351,148

3,127 payments

Research payments

$213,009

2 payments

Through program year 2020, $351,148 in general payments and $213,009 in research payments were reported against Eluvia (Stents).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2020 General $76,909 1,091
2020 Research $213,009 2
2019 General $274,238 2,036

Breakdown

Who paid General payments · program years 2019–2020
  1. Boston Scientific Corporation $351,148 3,127 payments
Top recipients General payments · program year 2020
  1. David Hurrell Cardiovascular Disease · Minneapolis, MN $6,550 9% · 3 payments
  2. Ravish Sachar Interventional Cardiology · Raleigh, NC $6,000 8% · 2 payments
  3. Robert Wilson Interventional Cardiology · Minneapolis, MN $5,650 7% · 3 payments
  4. Ehrin Armstrong Interventional Cardiology · Englewood, CO $4,553 6% · 4 payments
  5. Jeffrey Chambers Cardiovascular Disease · Minneapolis, MN $4,300 6% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Interventional Cardiology Internal Medicine $28,051 37% · 118 practitioners
  2. Cardiovascular Disease Internal Medicine $16,218 21% · 59 practitioners
  3. Vascular Surgery Surgery $14,868 19% · 219 practitioners
  4. Vascular & Interventional Radiology Radiology $9,899 13% · 86 practitioners
  5. Surgery $2,124 3% · 34 practitioners

The top 5 of 35 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Minnesota $20,528 27% · 17 recipients
  2. North Carolina $6,910 9% · 24 recipients
  3. New York $6,708 9% · 31 recipients
  4. Massachusetts $5,916 8% · 14 recipients
  5. Pennsylvania $5,143 7% · 54 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

3,127 general · 2 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record